A.I.dvisor tells us that CRDF and MGTX have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CRDF and MGTX's prices will move in lockstep.
Ticker / NAME | Correlation To CRDF | 1D Price Change % | ||
---|---|---|---|---|
CRDF | 100% | -5.19% | ||
MGTX - CRDF | 33% Poorly correlated | -3.93% | ||
VRPX - CRDF | 32% Poorly correlated | +0.04% | ||
RGNX - CRDF | 32% Poorly correlated | -7.20% | ||
APGE - CRDF | 31% Poorly correlated | -5.41% | ||
SYRE - CRDF | 31% Poorly correlated | -7.48% | ||
More |
Ticker / NAME | Correlation To CRDF | 1D Price Change % |
---|---|---|
CRDF | 100% | -5.19% |
solid tumors theme (2 stocks) | 72% Closely correlated | -1.01% |
medicine theme (3 stocks) | 33% Loosely correlated | -1.26% |
cancer theme (87 stocks) | 29% Poorly correlated | +0.89% |
treatment theme (61 stocks) | 29% Poorly correlated | +0.91% |
oncology theme (18 stocks) | 28% Poorly correlated | +0.37% |
More |